Loading...
Docoh

Eloxx Pharmaceuticals (ELOX)

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
Eloxx Pharmaceuticals: Q1 Earnings Insights
10 May 22
Earnings, News
Eloxx Pharmaceuticals (NASDAQ:ELOX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Eloxx Pharmaceuticals Q1 EPS $(0.13) Up From $(0.22) YoY
10 May 22
Earnings, News
Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.13) per share. This is a 40.91 percent increase over losses of $(0.22) per share from the same period last year.
HC Wainwright & Co. Maintains Neutral on Eloxx Pharmaceuticals, Lowers Price Target to $0.5
9 May 22
News, Price Target, Analyst Ratings
HC Wainwright & Co. analyst Andrew Fein maintains Eloxx Pharmaceuticals (NASDAQ:ELOX) with a Neutral and lowers the price target from $1 to $0.5.
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 1043 companies hit new 52-week lows.
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Apr 22
Movers
Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.
Stocks That Hit 52-Week Lows On Wednesday
27 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
25 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 721 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Friday
22 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 431 companies hit new 52-week lows.
Eloxx to Test Its Lead Product Candidate, ELX-02, In Rare Kidney Disease
31 Mar 22
Biotech, Earnings, News, Penny Stocks, Guidance, Health Care, Movers, Trading Ideas, General
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX)
Recap: Eloxx Pharmaceuticals Q4 Earnings
31 Mar 22
Earnings, News
Eloxx Pharmaceuticals (NASDAQ:ELOX) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Eloxx Pharmaceuticals Q4 EPS $(0.14) Misses $(0.12) Estimate
31 Mar 22
Earnings, News
Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share
Eloxx Pharma Highlights New Development Program For ELX-02 For Treatment Of Alport Syndrome
30 Mar 22
Biotech, News, FDA, General
Strong rationale for development for Alport syndrome as ELOX-02 has demonstrated significant readthrough in COL4A5 nonsense mutations in preclinical studies and is preferentially transported to kidney Initiation of
Eloxx Pharma Wins $15.9M Grant From Cystic Fibrosis Foundation
29 Mar 22
Biotech, News, FDA, General
Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating